Arrowstreet Capital’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-42,193
| Closed | -$41K | – | 1476 |
|
|
2023
Q2 | $41K | Buy |
+42,193
| New | +$41.7K | ﹤0.01% | 1193 |
|
|
2018
Q2 | – | Sell |
-65,528
| Closed | -$1.05M | – | 1353 |
|
|
2018
Q1 | $1.05M | Buy |
+65,528
| New | +$1.3M | ﹤0.01% | 862 |
|
|
2017
Q4 | – | Sell |
-27,200
| Closed | -$383K | – | 1426 |
|
|
2017
Q3 | $383K | Buy |
+27,200
| New | +$246K | ﹤0.01% | 972 |
|
|
2016
Q4 | – | Sell |
-185,137
| Closed | -$865K | – | 2642 |
|
|
2016
Q3 | $865K | Buy |
185,137
+91,391
| +97% | +$541K | ﹤0.01% | 1107 |
|
|
2016
Q2 | $616K | Sell |
93,746
-135,700
| -59% | -$959K | ﹤0.01% | 1097 |
|
|
2016
Q1 | $1.46M | Sell |
229,446
-377,074
| -62% | -$1.93M | 0.01% | 887 |
|
|
2015
Q4 | $3.66M | Buy |
606,520
+364,298
| +150% | +$2.08M | 0.02% | 632 |
|
|
2015
Q3 | $1.45M | Buy |
+242,222
| New | +$1.68M | 0.01% | 827 |
|
|
2015
Q2 | – | Sell |
-15,300
| Closed | -$93K | – | 1323 |
|
|
2015
Q1 | $93K | Sell |
15,300
-80,522
| -84% | -$536K | ﹤0.01% | 957 |
|
|
2014
Q4 | $664K | Buy |
+95,822
| New | +$705K | ﹤0.01% | 987 |
|
Arrowstreet Capital's SPPI Position: Q3 2023 in Review
Arrowstreet Capital sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 42,193 shares — an estimated $41K sold.
Arrowstreet Capital first reported a position in SPPI in Q4 2014 and held it in 10 quarters. The position peaked at $3.66M in Q4 2015. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- Arrowstreet Capital reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- Arrowstreet Capital sold 42,193 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $41K.
- Arrowstreet Capital first reported a position in Spectrum Pharmaceuticals Inc in Q4 2014 and held it in 10 quarters.
- Arrowstreet Capital's Spectrum Pharmaceuticals Inc position peaked at $3.66M in Q4 2015.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on Arrowstreet Capital's 13F filing for Q3 2023, filed 14 Nov 2023.